Prednisone Protocol for Cluster Headache
For adults with episodic cluster headache, initiate prednisone at 100 mg daily for 5 days, then taper by 20 mg every 3 days (total 17-day course), administered alongside verapamil for long-term prevention. This regimen demonstrated significant efficacy in reducing attack frequency during the critical period while verapamil reaches therapeutic levels 1.
Starting Dose and Initial Phase
The evidence strongly supports high-dose initiation at 100 mg daily rather than lower doses. The landmark 2021 randomized controlled trial by Obermann et al. demonstrated that 100 mg prednisone daily for 5 days significantly reduced mean attack frequency in the first week (7.1 attacks vs 9.5 in placebo, p=0.002) 1. This aligns with the 2024 VA/DoD headache guidelines, though they provide only weak recommendations due to limited high-quality evidence 2.
- Administer as a single morning dose (before 9 AM) to minimize HPA axis suppression 3
- Take with food or antacids to reduce gastric irritation 3
- Start verapamil concurrently at 40 mg three times daily, increasing to 120 mg three times daily by day 19 1
Tapering Schedule
After the 5-day high-dose phase, reduce by 20 mg every 3 days:
- Days 1-5: 100 mg daily
- Days 6-8: 80 mg daily
- Days 9-11: 60 mg daily
- Days 12-14: 40 mg daily
- Days 15-17: 20 mg daily
- Day 18: Discontinue
This structured taper was specifically validated for cluster headache 1, unlike the more gradual tapers used in other conditions. The rapid taper is appropriate given the short treatment duration and the goal of bridging to verapamil efficacy.
Duration and Rationale
Total treatment duration: 17 days maximum. This short course is critical because:
- Corticosteroids work rapidly in cluster headache, typically within 2-4 days 4
- The goal is to suppress attacks during the 2-3 week period required for verapamil to reach therapeutic effect 1, 5
- Prolonged courses (>4 weeks) increase adverse effects without additional benefit 6
- Single high-dose methylprednisolone (30 mg/kg IV) provided only 3.8 days of relief, demonstrating the need for a multi-day course rather than pulse therapy 4
Alternative Dosing Considerations
While 100 mg daily is the evidence-based standard, older literature and expert consensus suggest:
- Minimum effective dose: At least 100 mg methylprednisolone equivalent (approximately 125 mg prednisone) 5
- Some practitioners use up to 500 mg IV methylprednisolone daily for 5 days in severe cases 5, though this lacks comparative efficacy data
- Lower doses (<100 mg prednisone equivalent) are generally ineffective 6
The 2006 EFNS guidelines recommend "at least 100 mg methylprednisone (or equivalent corticosteroid)" which translates to approximately 125 mg prednisone, though the 2021 RCT validated 100 mg prednisone as effective 1, 5.
Critical Monitoring and Safety
Monitor for:
- Hyperglycemia - particularly in patients with diabetes risk factors
- Hypertension - check blood pressure during treatment
- Psychiatric symptoms - mood changes, insomnia (common at 71% incidence) 1
- Infection risk - though minimal with short courses
Contraindications to verify:
- Active infection
- Uncontrolled diabetes
- Peptic ulcer disease
- Severe hypertension
- Recent live vaccines
The 2021 trial found no serious adverse events attributable to prednisone, with most side effects being mild (headache, palpitations, dizziness, nausea) 1.
Common Pitfalls to Avoid
Underdosing: Using standard methylprednisolone dose packs (84 mg total over 6 days) provides inadequate steroid exposure compared to the validated regimen 7
Prolonged courses: Extending beyond 4 weeks increases adverse effects without improving outcomes 6. Attacks often recur when steroids are tapered regardless of duration 6
Monotherapy: Prednisone alone without concurrent verapamil initiation leads to relapse when steroids are discontinued 1, 6. Always start verapamil simultaneously.
Abrupt discontinuation: Even with this short course, taper as prescribed rather than stopping abruptly 3
Delayed initiation: Start within 30 days of cluster period onset for optimal efficacy 1
Efficacy Expectations
Patients should expect:
- Reduction in attack frequency within the first week (approximately 2-3 fewer attacks) 1
- Not complete remission - only 23% achieved complete headache freedom in the pivotal trial 1
- Temporary benefit - prednisone bridges to verapamil efficacy rather than providing definitive treatment 1, 6
The evidence demonstrates prednisone is effective for short-term attack suppression but requires concurrent preventive therapy for sustained benefit 1, 5, 6.